StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

4,4'-Dichlorbiphenyl

4,4'-Dichlorobiphenyl

HCID 16308
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
2050-68-2
Standard-SMILES
Clc1ccc(-c2ccc(Cl)cc2)cc1
InChIKey
YTBRNEUEFCNVHC-UHFFFAOYSA-N
Summenformel
C12H8Cl2
Durchschnittliche Molmasse
223,09 g/mol
Monoisotopische Masse
222,0003056

Überblick

4,4'-dichlorobiphenyl is a dichlorobiphenyl carrying chloro groups at positions 4 and 4' respectively. It is a dichlorobiphenyl and a member of monochlorobenzenes.

Namen und Bezeichner

Bevorzugter Name
4,4'-Dichlorobiphenyl
IUPAC
1-chloro-4-(4-chlorophenyl)benzene
Lokaler Name
4,4'-Dichlorbiphenyl
Englischer Name
4,4'-Dichlorobiphenyl
Summenformel
C12H8Cl2
Molmasse
223.1

Namen und Synonyme

4,4'-Dichlorobiphenyl2050-68-24,4'-DICHLORO-1,1'-BIPHENYLp,p-Dcbpp,p'-Dichlorobiphenyl1,1'-Biphenyl, 4,4'-dichloro-PCB 151-chloro-4-(4-chlorophenyl)benzeneBiphenyl, 4,4'-dichloro-4-DCB cpdDOF6S5DT2RDTXSID0022515
Weitere Namen anzeigen
pcb154,4'-CB4,4'-PCBBZ NO 15NSC 1141PCB NO 15p,p’-dcbpBALLSCHMITER NO 15
NSC-1141CHEBI:34364RefChem:53597DTXCID502515218-095-4PCB No. 15Biphenyl,4'-dichloro-4,4 inverted exclamation marka-Dichlorobiphenyl

Datenbank-Bezeichner

CAS
2050-68-2
PubChem CID
16308
DTXSID
DTXSID0022515
ChEMBL
CHEMBL14295
ChEBI
CHEBI:34364
UNII
DOF6S5DT2R

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
5,6
Polarare Oberfläche (TPSA)
0 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
0
Frei drehbare Bindungen
1
Schwere Atome
14
Formalladung
0
Komplexität
145

Experimentelle und physikochemische Eigenschaften

SpringerMaterials Properties13C nuclear magnetic resonance spectrum
LogP5.23
Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section141.8 Ų [M]+ [CCS Type: TIMS, Method: calibration with PAHs]

Physikochemische Eigenschaften

Schmelzpunkt
288 ℃ · 288℃
Siedepunkt
289.78 °C · 289.78°C (rough estimate)
Dichte
1.249 · 1.2490 (rough estimate)
Brechungsindex
1.594 · 1.5940 (rough estimate)
Flammpunkt
-12 ℃ · -12℃
storage temp.
2 · 2-8°C
Wasserlöslichkeit
53 ug/L · 53ug/L(25 ºC)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 7.1% (3 of 42) of reports.

Warning

H373 (92.9%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P273, P319, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationSubstance: 4,4'-dichlorobiphenyl
Hazard Classes and CategoriesSTOT RE 2 (92.9%)

Sicherheit und Schutzausrüstung

Minimum Risk LevelIntermediate Oral: 0.03 ug/kg/day (L134)

Toxikologische Informationen

Treatment · 1 Eintrag

There are no specific treatments for PCB poisoning, since it is not usually recognized until after substantial chronic exposure. Only preventing further exposure and treating the observed symptoms can be done. Acute inhalation can be treated by administering oxygen. (L4)

Health Effects · 1 Eintrag

The most common health effects of PCBs are skin conditions such as chloracne and rashes. Chronic PCB exposure has also been shown to cause liver, stomach and kidney, damage, jaundice, edema, anemia, changes in the immune system, behavioral alterations, and impaired reproduction. (L4)

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 2 Einträge

4,4'-Dichlorobiphenyl has known human metabolites that include 4,4-²-Dichloro-3-biphenylol.

PCBs are absorbed via inhalation, oral, and dermal routes of exposure. They are trasported in the blood, often bound to albumin. Due to their lipophilic nature they tend to accumulate in lipid-rich tissues, such as the liver, adipose, and skin. Metabolism of PCBs is very slow and varies based on the degree and position of chlorination. PCBs are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 enzymes to polar metabolites that can undergo conjugation with glutathione and glucuronic acid. The major metabolites are hydroxylated products which are excreted in the bile and faeces. The slow metabolism of PCBs means they tend to accumulate in body tissues. (L4, T6)

Verwendung und Herstellung

Uses · 1 Eintrag

PCBs were used as coolants and lubricants in transformers, capacitors, and other electrical devices (such as fluorescent lights and refridgerators) produced before 1977. PCBs may contaminate the air and water near hazardous waste sites. In addition, PCBs bioaccumulate in the environment and may be found in fish, meat, and dairy products. (L4)

Anwendungen

Verwenden4,4''-Dichlorobiphenyl is a polychlorinated biphenyl (PCB) congeners.

Vor- und nachgelagerte Produkte

Nachgelagerte Produkte

2,4'-Dichlorobiphenyl

Ergänzende Hinweise

DefinitionChEBI: A dichlorobiphenyl carrying chloro groups at positions 4 and 4' respectively.

Zugehörige Reaktionen

4
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 268508
HRID 268508als Produkt
Reaktionsgleichung von HRID 329313
HRID 329313als Produkt
Reaktionsgleichung von HRID 1108513
HRID 1108513als Produkt
Reaktionsgleichung von HRID 2119232
HRID 2119232als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
EC Number
218-095-4
Nikkaji
J7.868I
Henry's Law Constant
7 · 7.0×10-2 mol/(m3Pa) at 25℃, Li et al. (2003)
InChI
InChI=1S/C12H8Cl2/c13-11-5-1-9(2-6-11)10-3-7-12(14)8-4-10/h1-8H
InChIKey
YTBRNEUEFCNVHC-UHFFFAOYSA-N
SMILES
C1(C2=CC=C(Cl)C=C2)=CC=C(Cl)C=C1
CAS Datenbank
2050 · 2050-68-2(CAS DataBase Reference)
EPA chemische Informationen
4 · 4,4'-Dichlorobiphenyl (2050-68-2)
Exposure RoutesOral (L4) ; inhalation (L4) ; dermal (L4)
Toxicity Summary · 1 Eintrag

The mechanism of action varies with the specific PCB. Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. Most of the toxic effects of PCBs are believed to be results of Ah receptor binding. Other PBCs are believed to interfere with calcium channels and/or change brain dopamine levels. PCBs can also cause endocrine disurption by altering the production of thyroid hormones and binding to estrogen receptors, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. They will bioaccumulate by binding to receptor proteins such as uteroglobin. (A3, A4, A30, A66)

Signs and SymptomsChronic PCB exposure results in symptoms such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3)
Carcinogen Classification1, carcinogenic to humans. (L135)
Toxicity DataLD50: 1010 mg/kg (Oral, Rat) (T14) LD50: 880 mg/kg (Intraperitoneal, Mouse) (T14)

Sicherheitsdaten

wgk
3
ridadr
2315
RTECS-Nr.
DV3912500
risk_code
11-36/37/38-22-50/53-33-67-65-38
hazard_code
F,Xi,Xn,N
safety_code
16-26-33-36-61-60-35-62
hazard_class
9
packing_group
II